Amyloid Beta Exposed Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Amyloid-beta-exposed neurons represent a critical neuronal population in Alzheimer's disease (AD) pathophysiology. These neurons exist in an environment rich in amyloid-beta (Aβ) peptides, which exert toxic effects on synaptic function, calcium homeostasis, and neuronal survival. Understanding how neurons respond to amyloid-beta exposure is essential for developing effective AD therapeutics. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Disease-Specific Neurons | [4]
| Location | Cortex, Hippocampus, Basal Forebrain | [5]
| Cell Types | Pyramidal neurons, GABAergic interneurons, Cholinergic neurons | [6]
| Primary Neurotransmitter | Glutamate, GABA, Acetylcholine | [7]
| Key Markers | Amyloid-beta, BACE1, PSEN1, PSEN2, Synaptophysin |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000169 | type B pancreatic cell |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000169 | type B pancreatic cell | Medium |
Amyloid-beta is produced through proteolytic cleavage of the amyloid precursor protein (APP):
Amyloid-beta exposure leads to synaptic impairment before neuronal loss:
Amyloid-beta disrupts neuronal calcium regulation:
Aβ exposure induces oxidative damage:
Amyloid-beta impairs mitochondrial function:
Aβ activates glial responses:
The hippocampus shows early Aβ accumulation and neuronal vulnerability:
Layer-specific vulnerability in the cortex:
Early target of Aβ pathology:
Rational combinations target multiple pathways:
Anti-Aβ therapy + tau-targeted therapy
Synaptic protection + anti-inflammatory
Neurogenesis enhancement + neurotrophic support
Amyloid Precursor Protein
Amyloid-Beta
APP Processing Pathway
Oxidative Stress in AD
The study of Amyloid Beta Exposed Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Klein et al. Synaptotoxicity of Aβ oligomers (2019). 2019. ↩︎
Cline et al. Amyloid-beta and calcium dysregulation (2019). 2019. ↩︎
Manczak et al. Mitochondria and Aβ toxicity (2021). 2021. ↩︎
Heneka et al. Neuroinflammation in AD (2015). 2015. ↩︎
Puzzo et al. Amyloid-beta and synaptic plasticity (2015). 2015. ↩︎